long term side effects of retatrutide Retatrutide: A Promising Option for Non-Diabetic Weight Loss in Clinical Trials Retatrutide vs Mounjaro: A Doctor's

6.6 When to Refer Referral to a clinician or dietitian may be appropriate when: Persistent GI intolerance limits intake Weight loss exceeds 20% body weight Multiple laboratory abnormalities are present Underlying malabsorptive or gastrointestinal disease exists Patient is elderly or medically complex GLP-1 therapy should not occur in isolation from nutritional oversight when risk factors are present

These effects are often manageable and resolve upon discontinuation

Omada has already completed an initial commercial launch with a large enterprise customer that has more than 300,000 employees

Placebo managed just 2.1%

Brierley DI, Holt MK, Singh A et al (2021) Central and peripheral GLP-1 systems independently suppress eating

# ab107159, 1:250) and anti-GFAP (Dako, polyclonal, Cat